Gastroenterology — MCQs

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 1161: A 45-year-old female presents with a long-standing history of heartburn and regurgitation. Endoscopy reveals Barrett's esophagus. What is the primary concern for this patient?

A. Gastric ulcer
B. Esophageal cancer (Correct Answer)
C. Peptic stricture
D. Achalasia

Explanation: ***Esophageal cancer*** - Barrett's esophagus is a precancerous condition that significantly increases the risk of **adenocarcinoma** of the esophagus [3]. - Regular surveillance is necessary due to potential **malignant transformation** in patients with Barrett's esophagus [3]. *Achalasia* - This condition presents with **dysphagia** for solids and liquids and does not show a direct link to Barrett's esophagus. - It primarily affects the **lower esophageal sphincter**, leading to **esophageal dilation** rather than a concern for cancer [1]. *Peptic stricture* - While this may occur due to chronic gastroesophageal reflux, it is not as significant a concern as **esophageal cancer** in patients with Barrett's esophagus [2]. - Peptic strictures are typically **benign** and can be treated with dilation [1]. *Gastric ulcer* - Gastric ulcers are unrelated to Barrett's esophagus and present differently, mainly with **epigastric pain**. - They do not stem from **chronic reflux** and thus are not a primary concern in this patient.

Question 1162: Which of the following laboratory values is NOT included in the MELD score?

A. INR (International Normalized Ratio)
B. Serum bilirubin
C. Serum creatinine
D. Alkaline phosphatase (Correct Answer)

Explanation: ***Alkaline phosphatase*** - **Alkaline phosphatase** is a liver enzyme that can be elevated in various liver conditions, particularly those involving **biliary obstruction** [1], but it is not a component of the MELD score calculation. - The MELD score focuses on markers of **liver synthetic function** and **renal impairment** [2], not enzymes indicative of cholestasis or hepatocellular damage alone. *Serum bilirubin* - **Serum bilirubin** is a crucial component of the MELD score, reflecting the liver's ability to **process and excrete bilirubin**, a byproduct of red blood cell breakdown [1]. - Elevated bilirubin levels indicate **impaired liver function**, often seen in advanced liver disease. *Serum creatinine* - **Serum creatinine** is included in the MELD score to account for **renal dysfunction** [2], which is a common and serious complication in patients with end-stage liver disease. - **Kidney impairment** significantly impacts the prognosis of patients awaiting liver transplantation. *INR (International Normalized Ratio)* - The **INR** measures the **extrinsic pathway of coagulation** and reflects the liver's capacity to synthesize **clotting factors** (II, VII, IX, X). [2] - An elevated INR indicates **impaired liver synthetic function**, making it a key prognostic indicator in the MELD score.

Question 1163: Which test is most useful in differentiating between Irritable Bowel Syndrome (IBS) and organic gastrointestinal diseases?

A. Stool calprotectin
B. Colonoscopy (Correct Answer)
C. Abdominal ultrasound
D. Fecal occult blood test

Explanation: ***Colonoscopy*** - A definitive **colonoscopy** allows for direct visualization of the colonic mucosa, enabling the identification of **inflammation**, **ulcers**, or **polyps** characteristic of organic GI diseases [1]. - While IBS is a **functional disorder** with no visible abnormalities on colonoscopy, this procedure can rule out **inflammatory bowel disease (IBD)**, **colorectal cancer**, or **microscopic colitis** [1]. *Stool calprotectin* - **Stool calprotectin** is a marker of intestinal inflammation and is typically elevated in **inflammatory bowel disease (IBD)** but normal in IBS. - Although useful for screening out IBD, it does not provide definitive diagnosis or rule out other organic causes like **microscopic colitis** or **colorectal cancer**. *Abdominal ultrasound* - An **abdominal ultrasound** is primarily used to evaluate intra-abdominal organs like the liver, gallbladder, pancreas, and kidneys, but it has limited utility in visualizing the bowel wall or detecting microscopic inflammation. - It is not sensitive or specific enough to differentiate between IBS and many **organic gastrointestinal diseases** that affect the colon directly. *Fecal occult blood test* - A **fecal occult blood test** detects hidden blood in the stool, which can indicate **gastrointestinal bleeding** from conditions like **colorectal cancer**, **ulcers**, or **inflammatory bowel disease** [2]. - While positive results suggest a need for further investigation, a negative result does not rule out all organic diseases (e.g., microscopic colitis, celiac disease, or non-bleeding polyps) and is therefore not definitive for differentiating from IBS [2].

Question 1164: Which of the following statements about medical management of uncomplicated GERD is true?

A. Household measures such as tilting the bed can be effective.
B. PPIs are the most effective drug treatment for GERD. (Correct Answer)
C. An adequate dose of PPI for 8 weeks is the recommended treatment.
D. Long-term PPI therapy is associated with an increased risk of gastric malignancy.

Explanation: PPIs are the most effective drug treatment for GERD. [1] - Proton pump inhibitors (PPIs) are considered the most potent and effective medications for suppressing gastric acid secretion, which is the primary mechanism for treating GERD symptoms and healing esophagitis. - They work by irreversibly inhibiting the H+/K+-ATPase pump in gastric parietal cells, leading to a profound reduction in stomach acid. *Household measures such as tilting the bed can be effective.* - While lifestyle modifications like elevating the head of the bed, avoiding late meals, and dietary changes are often recommended, they are generally adjunctive measures and not the primary or most effective drug treatment for GERD symptoms. - These measures can help reduce reflux episodes but do not address the underlying acid secretion as effectively as medications. *An adequate dose of PPI for 8 weeks is the recommended treatment.* - An adequate dose of PPI for 8 weeks is indeed a common initial treatment course for GERD with esophagitis or severe symptoms but this statement refers to a specific treatment duration, not the general effectiveness of PPIs as a drug class. [1] - The most effective drug treatment refers to the class of medication that works best, which are PPIs. *Long-term PPI therapy is associated with an increased risk of gastric malignancy.* - While there are ongoing debates and studies regarding the long-term effects of PPIs, current evidence generally does not strongly support a direct causal link between long-term PPI therapy and an increased risk of gastric malignancy in the absence of Helicobacter pylori infection. [1] - Concerns about long-term PPI use often center around conditions like C. difficile infection, osteoporosis, and kidney disease, rather than gastric malignancy. [1]

Question 1165: Which of the following is the most sensitive and specific test for acute pancreatitis?

A. S.amylase
B. S.Alanine transaminase
C. S.lipase (Correct Answer)
D. C-reactive protein

Explanation: ***S.lipase*** - **Serum lipase** is considered the most sensitive and specific marker for **acute pancreatitis** because it remains elevated longer than amylase and is less commonly elevated in non-pancreatic conditions. - A level of **serum lipase** that is three times the upper limit of normal is highly indicative of **acute pancreatitis**. *S.amylase* - **Serum amylase** is often elevated in **acute pancreatitis**, but it is less specific than lipase, as it can also be elevated in other conditions like **salivary gland disease**, **bowel ischemia**, or **renal failure** [1]. - **Amylase** levels typically normalize within 3-5 days, whereas lipase levels can remain elevated for 8-14 days. *S.Alanine transaminase* - **Serum alanine transaminase (ALT)** is primarily a marker of **hepatocellular injury** and is not directly used for diagnosing **acute pancreatitis**. - While elevated **ALT** can sometimes suggest **gallstone pancreatitis** if significantly high (e.g., >150 U/L), it's not a diagnostic test for the pancreatitis itself. *C-reactive protein* - **C-reactive protein (CRP)** is an **acute-phase reactant** that indicates inflammation and tissue damage, and its levels rise in pancreatitis. - However, **CRP** is a non-specific marker of inflammation and is more useful for assessing the **severity** and **prognosis** of pancreatitis rather than for initial diagnosis [1].

Question 1166: Which enzyme is most specific for pancreatic pathology in the evaluation of chronic pancreatitis?

A. Amylase
B. Lipase (Correct Answer)
C. Elastase
D. Trypsin

Explanation: Lipase - **Lipase** is highly specific to the pancreas and is useful for diagnosing chronic pancreatitis, especially when evaluating for **pancreatic insufficiency**. - Its levels can remain elevated longer than amylase in acute pancreatitis, and it is less prone to elevation from non-pancreatic sources. *Amylase* - While elevated in pancreatic pathology, **amylase** can also be increased due to non-pancreatic conditions such as salivary gland issues, kidney failure, or certain cancers. - Its specificity for the pancreas is lower compared to lipase, and it may not be persistently elevated in chronic pancreatitis due to widespread destruction of acinar cells. *Elastase* - **Fecal elastase-1** is a sensitive and specific test for **exocrine pancreatic insufficiency**, a common feature of chronic pancreatitis [1]. - However, it measures pancreatic function by assessing the enzyme's presence in stool rather than being a direct marker of acute pancreatic injury in serum. *Trypsin* - **Trypsin** and **immunoreactive trypsinogen** are markers of pancreatic function, and elevated levels can suggest pancreatic damage. - However, like amylase, serum trypsin levels can also be affected by renal impairment and are not as widely used as lipase for routine diagnosis of chronic pancreatitis.

Question 1167: Which of the following is MOST characteristic of gastric ulcers compared to duodenal ulcers?

A. Pain is more common during the day than at night.
B. Pain is relieved with ingestion of food
C. Hematemesis is more common than melena in gastric ulcers (Correct Answer)
D. Usually occurs in older adults.

Explanation: No relevant references with a score >= 7 were provided to support the clinical characteristics of gastric versus duodenal ulcers in the explanation. Hematemesis is more common than melena in gastric ulcers; gastric ulcers are located in the stomach, so if they bleed, the blood is more likely to be vomited before it has been digested enough to turn black (melena). The closer the bleeding source is to the mouth in the GI tract, the more likely freshly passed blood will be bright red (hematemesis). Pain is more common during the day than at night. While gastric ulcer pain can occur at any time, it is not specifically more common during the day compared to at night as a characteristic differentiator from duodenal ulcers. Duodenal ulcer pain is often described as nocturnal or occurring several hours after a meal, but this option does not isolate a unique feature of gastric ulcers. Usually occurs in older adults. While the incidence of peptic ulcer disease can increase with age, stating that gastric ulcers usually occur in older adults is not a characteristic distinguishing them from duodenal ulcers, as both can affect various age groups, and duodenal ulcers are often seen in younger to middle-aged adults. This statement is too general and does not provide a specific differentiating feature. Pain is relieved with ingestion of food. This description is more characteristic of duodenal ulcers, where food can transiently buffer stomach acid, alleviating the pain. In contrast, gastric ulcer pain is often worsened by food intake, as eating stimulates acid secretion and gastric motility.

Question 1168: In men, what quantity of ethyl alcohol consumed daily for more than 10 years increases the relative risk of developing alcoholic liver disease?

A. 20g/d
B. 60g/d
C. 80g/d
D. 40g/d (Correct Answer)

Explanation: 40g/d - Chronic consumption of 40g/d or more of ethanol in men, and 20g/d or more in women, significantly increases the risk of developing alcoholic liver disease over 10 years [1]. - This threshold represents a level of regular alcohol intake that causes cumulative hepatic damage over time [1]. 20g/d - While 20g/d in women significantly increases the risk, in men, this amount is generally considered the threshold for low-risk drinking in the absence of other risk factors. - Consistent consumption at this level in men for more than 10 years would be very unlikely to raise the relative risk of developing alcoholic liver disease above that of the general population. 60g/d - This amount certainly carries a high risk of alcoholic liver disease, but it is above the minimum threshold required to significantly increase the relative risk. - The risk of cirrhosis and other severe liver damage escalates with intake greater than 40g/d [1]. 80g/d - Consumption at 80g/d represents a very high level of alcohol intake and is associated with a substantially elevated risk of severe alcoholic liver disease. - However, the question asks for the quantity that increases the relative risk, meaning the lowest dose above which the risk is significantly higher than baseline.

Question 1169: What is the most accurate method for diagnosing Gastroesophageal Reflux Disease (GERD)?

A. Histological study
B. Manometry
C. 24-hour pH recording and electrical impedance measurement (Correct Answer)
D. Barium swallow studies and Upper GI endoscopy

Explanation: ***24-hour pH recording and electrical impedance measurement*** - This method directly measures the **frequency and duration of acid reflux** into the esophagus, correlating symptoms with reflux episodes. - **Electrical impedance** also detects non-acidic reflux, making it the most comprehensive and accurate diagnostic tool for GERD. *Histological study* - While histology can show **esophageal inflammation** (esophagitis), this finding is not specific to GERD and can be caused by other conditions. - It does not directly assess the **frequency or severity of reflux episodes**. *Manometry* - Esophageal manometry measures the pressure and coordination of muscle contractions, primarily used to diagnose **motility disorders** such as achalasia. [1] - It assesses the integrity of the **lower esophageal sphincter (LES)** but does not quantify reflux events. [1] *Barium swallow studies and Upper GI endoscopy* - **Barium swallow** can identify anatomical abnormalities like hiatal hernias or severe reflux, but it has low sensitivity for diagnosing GERD itself. [1] - **Upper GI endoscopy** can visualize mucosal damage (esophagitis) consistent with GERD but does not confirm reflux is the cause of symptoms if the mucosa appears normal (non-erosive reflux disease). [1]

Question 1170: In which of the following conditions is non-surgical medical treatment for gallstones indicated?

A. Prophylaxis in patients at high risk for gallstone formation
B. Dissolution therapy candidates with radiolucent stones <15mm
C. Small cholesterol stones in patients unfit for surgery
D. Patient refusal of surgical intervention with cholesterol stones (Correct Answer)

Explanation: **Patient refusal of surgical intervention with cholesterol stones** - When a patient with **symptomatic gallstones** (even cholesterol stones) refuses surgery, medical dissolution therapy may be considered as an alternative, despite its limitations and lower efficacy compared to cholecystectomy. - This option prioritizes **patient autonomy** when surgical intervention is the standard but declined. *Small cholesterol stones in patients unfit for surgery* - While medical dissolution therapy can be considered for **small cholesterol stones**, being "unfit for surgery" in itself doesn't automatically mean medical treatment is indicated without symptoms. - Asymptomatic stones generally do not require treatment, regardless of surgical fitness; treatment is usually reserved for symptomatic cases or specific high-risk scenarios. *Dissolution therapy candidates with radiolucent stones <15mm* - This describes ideal candidates for dissolution therapy using oral bile acids (e.g., **ursodeoxycholic acid**). - The size and radiolucency (indicating cholesterol stones) are important criteria, but this option isn't the *most likely* sole indication for non-surgical treatment when compared to a patient who actively refuses surgery, which forces consideration of alternatives even if less effective. *Prophylaxis in patients at high risk for gallstone formation* - Prophylactic treatment for gallstones is generally **not indicated** even in high-risk patients (e.g., rapid weight loss, bariatric surgery) unless they become symptomatic [1]. - The focus is usually on watchful waiting or, in very high-risk scenarios (e.g., post-bariatric surgery), ursodeoxycholic acid might be used to prevent stone formation, but this is a specific prophylactic use, not a direct treatment for existing stones.

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free